Novartis Delivers Solid Growth in Q3
Novartis, an innovative medicines company, has reported solid sales and core operating income growth in Q3, along with strong pipeline progress.
The company's mission is to "reimagine medicine to improve and extend people's lives" and empower patients, healthcare professionals, and societies in the face of serious disease. Novartis medicines reach 296 million people worldwide.
Resources and Commitments
- Resources for patients and caregivers, including clinical trial recruiting and side effects reporting
- Resources for physicians and healthcare professionals, including clinical trial recruiting and grant funding
- Commitments to making a positive impact on the world, including providing access to innovative medicines and upholding high ethical standards
Our medicines reach 296 million people worldwide.
Novartis also provides information on its environmental, social, and governance commitments, as outlined in the Novartis in Society Integrated Report.
Author's summary: Novartis reports solid Q3 growth and progress.
More News
- Patrick Mahomes’ immediate words on Travis Kelce after victory in the Chiefs Commanders game
- 9 Black Actresses Who Went From Broadway To The Hollywood Big Screen
- Free Christmas stocking knitting pattern: A stylish, festive make to start now
- Glowing sperm helps to reveal secrets of mosquito sex
- The Game of Wool: Full list of contestants for Tom Daley's new knitting show on Channel 4
- NGP-backed Cygnet Energy to buy Kiwetinohk Energy for $1bn | PE Hub
- Art the Clown Owes One of His 'Terrifier' Actresses a Lot of Money
- New president of The Church of Jesus Christ of Latter-day Saints inherits a global faith far more diverse than many realize – Baptist News Global
- Gaza Ceasefire Tested as Israel and Hamas Exchange Fire and Blame
- Africa: Saving the Pancake Tortoise - a 'Living Emblem' of Kenya's Natural Heritage